enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
0.9056
+0.1242 (15.89%)
At close: Sep 15, 2025, 4:00 PM EDT
0.9000
-0.0056 (-0.62%)
After-hours: Sep 15, 2025, 6:47 PM EDT
enVVeno Medical Market Cap
enVVeno Medical has a market cap or net worth of $17.43 million as of September 15, 2025. Its market cap has decreased by -76.20% in one year.
Market Cap
17.43M
Enterprise Value
-16.83M
1-Year Change
-76.20%
Ranking
Category
Stock Price
$0.91
Market Cap Chart
Since May 31, 2018, enVVeno Medical's market cap has decreased from $40.00M to $17.43M, a decrease of -56.42%. That is a compound annual growth rate of -10.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 15.04M | -71.60% |
| Dec 31, 2024 | 52.96M | -22.63% |
| Dec 29, 2023 | 68.45M | 41.69% |
| Dec 30, 2022 | 48.31M | -22.58% |
| Dec 31, 2021 | 62.40M | 222.87% |
| Dec 31, 2020 | 19.33M | 96.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |